Liquid chromatography-tandem MS/MS method for simultaneous quantification of paracetamol, chlorzoxazone and aceclofenac in human plasma: An application to a clinical pharmacokinetic study
dc.Affiliation | October University for modern sciences and Arts (MSA) | |
dc.contributor.author | Helmy, MI | |
dc.contributor.author | Toubar, SS | |
dc.contributor.author | Elshahed, MS | |
dc.contributor.author | Hegazy, MA | |
dc.contributor.author | Mohamed, D | |
dc.date.accessioned | 2020-03-14T13:51:14Z | |
dc.date.available | 2020-03-14T13:51:14Z | |
dc.date.issued | 2018-07 | |
dc.description | WOS:000434409100019 | en_US |
dc.description.abstract | A facile, fast and specific method based on liquid chromatography-tandem mass spectrometry (LC-MS/MS) for the simultaneous quantitation of paracetamol, chlorzoxazone and aceclofenac in human plasma was developed and validated. Sample preparation was achieved by liquid-liquid extraction. The analysis was performed on a reversed-phase C-18 HPLC column (5m, 4.6x50mm) using acetonitrile-10mM ammonium formate pH3.0 (65:35, v/v) as the mobile phase where atrovastatin was used as an internal standard. A very small injection volume (3L) was applied and the run time was 2.0min. The detection was carried out by electrospray positive and negative ionization mass spectrometry in the multiple-reaction monitoring mode. The developed method was capable of determining the analytes over the concentration ranges of 0.03-30.0, 0.015-15.00 and 0.15-15.00g/mL for paracetamol, chlorzoxazone and aceclofenac, respectively. Intraday and interday precisions (as coefficient of variation) were found to be 12.3% with an accuracy (as relative error) of +/- 5.0%. The method was successfully applied to a pharmacokinetic study of the three analytes after being orally administered to six healthy volunteers | en_US |
dc.description.sponsorship | Helwan University | en_US |
dc.description.uri | https://www.scimagojr.com/journalsearch.php?q=23942&tip=sid&clean=0 | |
dc.identifier.doi | https://doi.org/ | |
dc.identifier.issn | 0269-3879 | |
dc.identifier.other | https://doi.org/ | |
dc.identifier.uri | https://t.ly/7xj8W | |
dc.language.iso | en_US | en_US |
dc.publisher | WILEY | en_US |
dc.relation.ispartofseries | BIOMEDICAL CHROMATOGRAPHY;Volume: 32 Issue: 7 | |
dc.subject | university of aceclofenac | en_US |
dc.subject | chlorzoxazone | en_US |
dc.subject | HPLC-MS | en_US |
dc.subject | MS | en_US |
dc.subject | human plasma | en_US |
dc.subject | paracetamol | en_US |
dc.subject | pharmacokinetic study | en_US |
dc.subject | PHARMACEUTICAL DOSAGE FORM | en_US |
dc.subject | MASS-SPECTROMETRY | en_US |
dc.subject | QUANTITATIVE-DETERMINATION | en_US |
dc.subject | HPLC METHOD | en_US |
dc.subject | RP-HPLC | en_US |
dc.subject | RAT PLASMA | en_US |
dc.subject | ACETAMINOPHEN | en_US |
dc.subject | PSEUDOEPHEDRINE | en_US |
dc.subject | METABOLITES | en_US |
dc.title | Liquid chromatography-tandem MS/MS method for simultaneous quantification of paracetamol, chlorzoxazone and aceclofenac in human plasma: An application to a clinical pharmacokinetic study | en_US |
dc.type | Article | en_US |